All the news Showing 6 of 676 articles from: TherapiesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Pharmasset Initiates Phase 2b ATOMIC Trial of PSI-7977 for Multiple HCV Genotypes PR Newswire / 30 March 2011 Achillion ACH-1625 hepatitis drug shows promise in mid-stage trial Reuters / 30 March 2011 Next Stage for Biotron's Hep C Drug Hepatitis Central / 23 March 2011 Who will win the hepatitis C market? Seeking Alpha / 15 March 2011 The Hepatitis C Pipeline Report Treatment Action Group / 09 March 2011 Telaprevir works well for people with HIV/HCV co-infection Liz Highleyman / 02 March 2011 The experimental hepatitis C virus (HCV) protease inhibitor telaprevir, used with pegylated interferon plus ribavirin, produced good virological response in the first study of HIV/HCV co-infected individuals, according to interim data presented on Wednesday ... ← Prev1...6465666768Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive